DMS Group secures strategic financing from the EIB

DMS Group, a specialist in medical imaging, has secured up to €20 million in funding from the European Investment Bank (EIB). Supported by the European Union's InvestEU program, this funding aims to boost innovation. Structured in three tranches, it will accelerate the development of new technological solutions in radiology and bone densitometry.

The funding must also improve the industrial capabilities of the Gallargues-le-Montueux site and support commercial efforts until 2030. The expenditures, mainly in France, will be devoted to innovation and the expansion of DMS Group in international markets.

The financing tranches include warrants for shares (BSAs) for the EIB, according to the terms of each tranche, with a combined maturity of 6 years. The initial drawdown of €4 million, subject to contractual conditions, will commence upon fulfillment of these conditions.